News & Analysis on Clinical Trial Services & Contract Research And Development
PEOPLE ON THE MOVE
Celerion appoints new CMO Marc Hoffman
By Dani Bancroft
- Last updated on
Nebraska, US-based Celerion Inc. has elected Marc Hoffman as its new Chief Medical Officer (CMO).
Celerion is a provider of early clinical research and translational clinical pharmacology services, such as data management and biometrics, PK/PD analysis, bioanalytical services, medical writing, and regulatory and drug development program management.
Marc joins Celerion having also served as CMO for Patient Ip and Theorem Clinical Research – where he was also Senior VP and General Manager over the Biopharmaceutical Business.
He has also held positions in Medical and Scientific Affairs at Baxter, Hospira and Covance, providing senior-level strategic direction for Phase II-IV programs.